GlobalData on MSN1d
AC Immune’s stock jumps after Parkinson’s therapy shows signs of benefitAC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...
AC Immune SA (ACIU) has released an update. AC Immune SA announced promising interim results from its Phase 2 trial of the ACI-7104.056 ...
The Lafayette Area Parkinson's Support, known as LeAPS, is a new nonprofit that will be offered to those impacted by ...
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
A new study that aims to understand the genetics of Parkinson’s has been held up by the need for 7000 Australians without a ...
The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
An oral presentation at the Michael J. Fox Foundation’s 16 th Annual Parkinson’s Disease Therapeutics Conference in October 2024 in New York, NY. A virtual webinar hosted by Gain Therapeutics in ...
Deep Fusion Films' Ben Field speaks to Yahoo UK about how surprised the stars who have been on the AI podcast are by the "compassionate" interviews.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback